Tolerability and efficacy of antihypertensive treatment with cilazapril in general practice?

Cardiology (Switzerland)

Volumn 87, Issue 1, 1996, Pages 54-59

  Rosenthal, J R ^a   Osowski, U ^b  

^a UNIVERSITY OF ULM   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

Angiotensin converting enzyme inhibitor; Cilazapril; Hypertension; Tolerability

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; COUGHING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0029656138     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177060     Document Type: Article

References (24)

1. Gruene S, Weisser B, Kraft K. et al: Comparison of casual ambulatory and self-measured blood pressure in a long-term study with cilaza-pril and atenolol. Am J Med 1993:94:715.
2. Lacourcière Y, Poirier L. Provencher P, et al: Antihypertensive effects of cilazapril, 2.5 and 5 mg. once daily versus placebo on ambulatory blood pressure following single-and repeat-dose administration. J Cardiovasc Pharmacol 1991:18:219.
3. Bursztyn M. Kobrin I, Fidel J. et al: Improved function with cilazapril in hypertensive type II diabetics with chronic renal failure. J Cardiovasc Pharmacol 1991:18:337.
4. Haberbosch RW, Osterziel KJ, Förderer T. et al: Kardioreparalive Effekte der ACE-Hem-mer. Klin Wochenschr 1992: 69(suppl 29): 16.
5. Phillips PJ. Phillipou G. Bowen KM. et al: Diabetic microalbuminuria and cilazapril. Am J Med 1993; 94/4A:585-605.
6. Fiorctto P, Frigato F, Velussi M. et al: Effects of angiotensin converting enzyme inhibitors and calcium antagonists on a trial natriuretic peptide release and action on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992:5:837.
7. Kogler P: Cilazapril: A new non-thiol-contain-ing angiotensin-converting enzyme inhibitor. Am J Med 1989:87(suppl 6B);60S.
8. Wenger NK. Mattson ME, Furgerg CD. el al: Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, Le Jacq, 1984.
9. Anonymous: Bundesanzeiger. August 13. 1991. No 149.
10. The Fifth Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intent Med 1993:153: 154.
11. Grossman E, Messerli FH: End-organ disease in hypertension: What have we learned? J Cardiovasc Pharmacol 1992:20(suppl 10):S1-6.
12. Kännel WB: Potency of vascular risk factors as the basis for antihypertensive therapy. F.ur Heart J 1992:13(suppl G):34-42.
13. Hollenberg NK: Treatment of hypertension: The place of angiotensin-converting enzyme inhibitors in the nineties. J Cardiovasc Pharmacol 1992;20(supp! 10):S29-32.
14. Santaro D. Natali A, Palombo C, et al: Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 1992:20:181.
15. Testa MA, Anderson RB, Nackley JF, et al: Quality of life and antihypertensive therapy in men. N Engl J Med 1993:328:907-913.
16. Schiffrin E. Den LY, Larochellc P. et al: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with angiotensin 1-converting enzyme inhibitor. Am J Hvpertens 1995:8: 229-236.
17. Fressinaud P, Berrut G. Gallois H: Activité antihypertensive, acceptabilité clinique et biologique du perindopril: principaux résultats chez 23640 hypertendus légers à modérés traités pendant 6 mois en médecine générale. Ann Cardiol Angiol (Paris) 1993:42:51.
18. Fritschka E. Distler A: Hochdrucktherapie im Alter. Fortschr Med 1989; 107:662.
19. Lewis EJ, Hunsicker LC, Bain RP, et al: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. New Engl J Med 1993:329:1456.
20. Israili ZF, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992:117:234.
21. Lefebre J. Poirier L. Lacourcière Y: Prospective trial on captopril-related cough. Ann Phar-macolher 1992:26:161.
22. Chalmers D. Whitehead A. Lawson DH: Postmarketing surveillance of captopril for hypertension. BrJ Clin Pharmacol 1992:43:215
23. Lederle RM: Fixe Arzneimittelkombination von ACE-Hemmer plus Diuretikum. Fortschr Med 1991:109:621.
24. Fletcher AE, Bulpitt CJ. Chase DM. et al: Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension 1992;19:499-507.